CLINICAL

Response: Renal dosing of allopurinol results in suboptimal gout care by T Neogi et al
Pascal Richette, Michael Doherty, Eliseo Pascual, Thomas Bardin

Annals of the Rheumatic Diseases Jan 2017, 76 (1) e2; DOI: 10.1136/annrheumdis-2016-210356
Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
Leonard Calabrese, Vamsidhar Velcheti

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 1-3; DOI: 10.1136/annrheumdis-2016-209782
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Karin Hellgren, Lene Dreyer, Elizabeth V Arkema, Bente Glintborg, Lennart T H Jacobsson, Lars-Erik Kristensen, Nils Feltelius, Merete Lund Hetland, Johan Askling

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 105-111; DOI: 10.1136/annrheumdis-2016-209270
The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor
S Ajeganova, H W van Steenbergen, M K Verheul, K Forslind, I Hafström, R E M Toes, T W J Huizinga, B Svensson, L A Trouw, A H M van der Helm-van Mil

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 112-118; DOI: 10.1136/annrheumdis-2015-208870
How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins
Aase Haj Hensvold, Thomas Frisell, Patrik K E Magnusson, Rikard Holmdahl, Johan Askling, Anca Irinel Catrina

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 119-125; DOI: 10.1136/annrheumdis-2015-208980
Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists
M Hifinger, M Hiligsmann, S Ramiro, V Watson, J L Severens, B Fautrel, T Uhlig, R van Vollenhoven, P Jacques, J Detert, J Canas da Silva, C A Scirè, F Berghea, L Carmona, M Péntek, A Keat, A Boonen

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 126-132; DOI: 10.1136/annrheumdis-2016-209202
Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure
Jasvinder A Singh, Shaohua Yu

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 133-139; DOI: 10.1136/annrheumdis-2015-209046
Does knee replacement surgery for osteoarthritis improve survival? The jury is still out
Devyani Misra, Na Lu, David Felson, Hyon K Choi, John Seeger, Thomas Einhorn, Tuhina Neogi, Yuqing Zhang

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 140-146; DOI: 10.1136/annrheumdis-2016-209167
Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis
Ryan W Gan, M Kristen Demoruelle, Kevin D Deane, Michael H Weisman, Jane H Buckner, Peter K Gregersen, Ted R Mikuls, James R O'Dell, Richard M Keating, Tasha E Fingerlin, Gary O Zerbe, Michael J Clare-Salzler, V Michael Holers, Jill M Norris

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 147-152; DOI: 10.1136/annrheumdis-2016-209154
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus
Kendra A Young, Melissa E Munroe, Joel M Guthridge, Diane L Kamen, Timothy B Niewold, Gary S Gilkeson, Michael H Weisman, Mariko L Ishimori, Jennifer Kelly, Patrick M Gaffney, Kathy H Sivils, Rufei Lu, Daniel J Wallace, David R Karp, John B Harley, Judith A James, Jill M Norris

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 153-158; DOI: 10.1136/annrheumdis-2016-209157

Main menu

CLINICAL

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CLINICAL

Pages